Cite
HARVARD Citation
Anz, D. et al. (n.d.). The dipeptidylpeptidase‐IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses. Diabetes, obesity & metabolism. 16 (6), pp. 569-572. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anz, D. et al. (n.d.). The dipeptidylpeptidase‐IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses. Diabetes, obesity & metabolism. 16 (6), pp. 569-572. [Online].